Financhill
Back

Cocrystal Pharma Stock Predictions

Cocrystal Pharma Stock Forecast

  • Is Cocrystal Pharma Stock Undervalued?
    The current Cocrystal Pharma [COCP] share price is $2.19. The Score for COCP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • COCP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Cocrystal Pharma Stock Go Up Next Year?

Data Unavailable

Cocrystal Pharma Stock Rating

Data Unavailable

Cocrystal Pharma Stock Price History

Is COCP stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COCP is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
cocrystalpharma.com

52-Week Data

52-Week High:
3.10
52-Week Low:
1.33

Prediction Charts

Market Cap:
22.3M
Price in USD:
2.19
Volume:
60.1K
Beta:
1.13

Technical Analysis

SMA50:
1.96
SMA100:
1.87
SMA200:
1.91
52-Wk Change:
18.38%

Stock Predictions

  • Is Cocrystal Pharma stock public?
    Yes, Cocrystal Pharma is a publicly traded company.
  • What is the Cocrystal Pharma stock quote today?
    The Cocrystal Pharma stock price is 2.19 USD today.
  • How to buy Cocrystal Pharma stock online?
    You can buy Cocrystal Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 2.13 2.00 2.13 2.00
Dec-4 1.96 1.94 2.00 1.94
Dec-5 1.93 1.88 1.98 1.88
Dec-6 1.88 1.90 1.95 1.81
Dec-9 1.90 1.96 2.15 1.90
Dec-10 1.99 1.98 2.03 1.96
Dec-11 1.92 1.88 1.94 1.87
Dec-12 1.85 1.86 1.99 1.85
Dec-13 1.83 1.91 1.97 1.83
Dec-16 1.91 2.02 2.07 1.91
Dec-17 2.10 1.98 2.10 1.92
Dec-18 1.97 2.24 2.30 1.90
Dec-19 2.19 2.10 2.30 2.02
Dec-20 2.12 2.19 2.33 2.02

Cocrystal Pharma Earnings

Data Unavailable

Cocrystal Pharma Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and a decrease next year of $0.25 per share.

* Cocrystal Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.